What question did this study set out to answer?

The study aims to validate the performance of various biomarker panels for early detection of pancreatic cancer.

March 25, 2026Open Access

Pancreatic Cancer Detection Consortium Biomarker Bakeoff: A Phase 2 blinded biomarker validation and panel discovery study

Key Points

The study aims to validate the performance of various biomarker panels for early detection of pancreatic cancer.
Conducted a blinded validation study of biomarker panels.
Utilized the CA19-9/FUT2/3 panel as a benchmark.
Provided recommendations for future studies on biomarker evaluation.
CA19-9/FUT2/3 panel was identified as the best performing biomarker.
Larger studies are needed to further assess the efficacy of the selected panels.

Abstract

The CA19-9/FUT2/3 panel was the best performing panel in this biomarker bakeoff. Its evaluation in larger studies is warranted. Biomarker bakeoffs are an effective strategy for comparing the performance of promising biomarkers for pancreatic cancer early detection, and the PCDC is well poised to conduct such studies. Recommendations for performing such studies are provided.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Oberg et al. (Mon,) studied this question.

synapsesocial.com/papers/69c37acab34aaaeb1a67ca1e https://doi.org/https://doi.org/10.1158/1078-0432.ccr-25-4061

Bookmark

View Full Paper